N803 Clinical Trials
2 recruitingDrug
Phase 11Phase 21
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Neuroblastoma Recurrent
St. Jude Children's Research Hospital54 enrolled4 locationsNCT07085338
Recruiting
Phase 1
Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma
Non Hodgkin's Lymphoma Refractory/Relapsed
ImmunityBio, Inc.20 enrolled2 locationsNCT05618925